Haleon plc (NYSE:HLN) Receives $10.95 Consensus Target Price from Brokerages

Haleon plc (NYSE:HLN) has been assigned an average rating of “Moderate Buy” from the seven analysts that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among analysts that have covered the stock in the last year is $10.95.

A number of equities analysts have issued reports on the stock. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Finally, UBS Group raised Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st.

Hedge Funds Weigh In On Haleon

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. AE Wealth Management LLC raised its stake in Haleon by 6.1% during the 2nd quarter. AE Wealth Management LLC now owns 19,199 shares of the company’s stock valued at $159,000 after acquiring an additional 1,098 shares in the last quarter. Lake Street Advisors Group LLC raised its stake in shares of Haleon by 5.4% during the third quarter. Lake Street Advisors Group LLC now owns 22,395 shares of the company’s stock valued at $237,000 after purchasing an additional 1,143 shares in the last quarter. Synovus Financial Corp lifted its holdings in Haleon by 0.8% in the third quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock worth $1,575,000 after purchasing an additional 1,216 shares during the period. Hexagon Capital Partners LLC grew its position in Haleon by 18.5% in the 3rd quarter. Hexagon Capital Partners LLC now owns 7,933 shares of the company’s stock valued at $84,000 after buying an additional 1,238 shares in the last quarter. Finally, Brown Brothers Harriman & Co. increased its stake in Haleon by 21.4% during the 2nd quarter. Brown Brothers Harriman & Co. now owns 7,569 shares of the company’s stock valued at $63,000 after buying an additional 1,334 shares during the period. 6.67% of the stock is owned by institutional investors.

Haleon Trading Up 0.5 %

Haleon stock opened at $9.24 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. Haleon has a 1 year low of $7.89 and a 1 year high of $10.80. The firm’s 50-day moving average is $9.54 and its 200-day moving average is $9.69. The company has a market cap of $41.80 billion, a P/E ratio of 27.16, a PEG ratio of 2.52 and a beta of 0.29.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.